Abstract
Cytoplasmic RNA granules represent subcellular compartments that are enriched in protein-bound RNA species. RNA granules are produced by evolutionary divergent eukaryotes, including yeast, mammals, and plants. The functions of cytoplasmic RNA granules differ widely. They are dictated by the cell type and physiological state, which in turn is determined by intrinsic cell properties and environmental factors. RNA granules provide diverse cellular functions. However, all of the granules contribute to aspects of RNA metabolism. This is exemplified by transcription, RNA storage, silencing, and degradation, as well as mRNP remodeling and regulated translation. Several forms of cytoplasmic mRNA granules are linked to normal physiological processes. For instance, they may coordinate protein synthesis and thereby serve as posttranscriptional “operons”. RNA granules also participate in cytoplasmic mRNA trafficking, a process particularly well understood for neurons. Many forms of RNA granules support the preservation of somatic cell performance under normal and stress conditions. On the other hand, severe insults or disease can cause the formation and persistence of RNA granules that contribute to cellular dysfunction, especially in the nervous system. Neurodegeneration and many other diseases linked to RNA granules are associated with aging. Nevertheless, information related to the impact of aging on the various types of RNA granules is presently very limited. This review concentrates on cytoplasmic RNA granules and their role in somatic cell maintenance. We summarize the current knowledge on different types of RNA granules in the cytoplasm, their assembly and function under normal, stress, or disease conditions. Specifically, we discuss processing bodies, neuronal granules, stress granules, and other less characterized cytoplasmic RNA granules. Our focus is primarily on mammalian and yeast models, because they have been critical to unravel the physiological role of various RNA granules. RNA granules in plants and pathogens are briefly described. We conclude our viewpoint by summarizing the emerging concepts for RNA granule biology and the open questions that need to be addressed in future studies.
Journal Section:
Editor's choice
References
1.
Hernandez-Verdun D: The nucleolus: a model for the organization of nuclear functions. Histochem Cell Biol 2006; 126: 135–148.
[PubMed]
2.
Anderson P, Kedersha N: RNA granules. J Cell Biol 2006; 172: 803–808.
[PubMed]
3.
Mahboubi H, Stochaj U: Cytoplasmic stress granules: dynamic modulators of cell signaling and disease. Biochim Biophys Acta 2017; 1863: 884–895.
[PubMed]
4.
Cougot N, Cavalier A, Thomas D, Gillet R: The dual organization of P-bodies revealed by immunoelectron microscopy and electron tomography. J Mol Biol 2012; 420: 17–28.
[PubMed]
5.
Rao BS, Parker R: Numerous interactions act redundantly to assemble a tunable size of P bodies in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2017; 114:E9569–E9578.
[PubMed]
6.
Kaganovich D: there is an inclusion for that: material properties of protein granules provide a platform for building diverse cellular functions. Trends Biochem Sci 2017; 42: 765–776.
[PubMed]
7.
Zhu L, Brangwynne CP: Nuclear bodies: the emerging biophysics of nucleoplasmic phases. Curr Opin Cell Biol 2015; 34: 23–30.
[PubMed]
8.
Panas MD, Ivanov P, Anderson P: Mechanistic insights into mammalian stress granule dynamics. J Cell Biol 2016; 215: 313–323.
[PubMed]
9.
Aguilera-Gomez A, Rabouille C: Membrane-bound organelles versus membrane-less compartments and their control of anabolic pathways in Drosophila. Dev Biol 2017; 428: 310–317.
[PubMed]
10.
Protter DSW, Rao BS, Van Treeck B, Lin Y, Mizoue L, Rosen MK, Parker R: Intrinsically disordered regions can contribute promiscuous interactions to RNP granule assembly. Cell Reports 2018; 22: 1401–1412.
[PubMed]
11.
Buchan JR: mRNP granules. Assembly, function, and connections with disease. RNA Biol 2014; 11: 1019–1030.
[PubMed]
12.
Tsekrekou M, Stratigi K, Chatzinikolaou G: The nucleolus: in genome maintenance and repair. Int J Mol Sci 2017; 18:E1411.
[PubMed]
13.
Khanna N, Hu Y, Belmont AS: HSP70 transgene directed motion to nuclear speckles facilitates heat shock activation. Curr Biol 2014; 24: 1138–1144.
[PubMed]
14.
Mahboubi H, Stochaj U: Nucleoli and stress granules: connecting distant relatives. Traffic 2014; 15: 1179–1193.
[PubMed]
15.
Nunes VS, Moretti NS: Nuclear subcompartments: an overview. Cell Biol Int 2017; 41: 2–7.
[PubMed]
16.
Yamazaki T, Hirose T: The building process of the functional paraspeckle with long non-coding RNAs. Front Biosci (Elite Ed) 2015; 7: 1–41.
[PubMed]
17.
Rajgor D, Shanahan CM: RNA granules and cytoskeletal links. Biochem Soc Trans 2014; 42: 1206–1210.
[PubMed]
18.
Singh G, Pratt G, Yeo GW, Moore MJ: The clothes make the mRNA: past and present trends in mRNP fashion. Annu Rev Biochem 2015; 84: 325–354.
[PubMed]
19.
Decker CJ, Parker R: P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol 2012; 4:a012286.
[PubMed]
20.
Hubstenberger A, Courel M, Benard M, Souquere S, Ernoult-Lange M, Chouaib R, Yi Z, Morlot JB, Munier A, Fradet M, Daunesse M, Bertrand E, Pierron G, Mozziconacci J, Kress M, Weil D: P-body purification reveals the condensation of repressed mRNA regulons. Mol Cell 2017; 68: 144–157.e145.
[PubMed]
21.
Hoyle NP, Castelli LM, Campbell SG, Holmes LE, Ashe MP: Stress-dependent relocalization of translationally primed mRNPs to cytoplasmic granules that are kinetically and spatially distinct from P-bodies. J Cell Biol 2007; 179: 65–74.
[PubMed]
22.
Khong A, Matheny T, Jain S, Mitchell SF, Wheeler JR, Parker R: The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. Mol Cell 2017; 68: 808–820.e805.
[PubMed]
23.
Leung AKL, Sharp PA: MicroRNA functions in stress responses. Mol Cell 2010; 40: 205–215.
[PubMed]
24.
Buchan JR, Parker R: Eukaryotic stress granules: the ins and outs of translation. Mol Cell 2009; 36: 932–941.
[PubMed]
25.
Moujaber O, Mahboubi H, Kodiha M, Bouttier M, Bednarz K, Bakshi R, White J, Larose L, Colmegna I, Stochaj U: Dissecting the molecular mechanisms that impair stress granule formation in aging cells. Biochim Biophys Acta 2017; 1864: 475–480.
[PubMed]
26.
Walter P, Ron D: The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334: 1081–1086.
[PubMed]
27.
Zheng D, Chen C-YA, Shyu A-B: Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation. RNA 2011; 17: 1619–1634.
[PubMed]
28.
Eulalio A, Behm-Ansmant I, Izaurralde E: P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 2007; 8: 9–22.
[PubMed]
29.
Ayache J, Benard M, Ernoult-Lange M, Minshall N, Standart N, Kress M, Weil D: P-body assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L complexes. Mol Biol Cell 2015; 26: 2579–2595.
[PubMed]
30.
Zheng D, Ezzeddine N, Chen CY, Zhu W, He X, Shyu AB: Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells. J Cell Biol 2008; 182: 89–101.
[PubMed]
31.
Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E: P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol 2007; 27: 3970–3981.
[PubMed]
32.
Patranabis S, Bhattacharyya SN: P-body-induced inactivation of let-7a miRNP prevents the death of growth factor-deprived neuronal cells. FASEB J 2017; 32: 1493–1509.
[PubMed]
33.
Herrero AB, Moreno S: Lsm1 promotes genomic stability by controlling histone mRNA decay. EMBO J 2011; 30: 2008–2018.
[PubMed]
34.
Loll-Krippleber R, Brown GW: P-body proteins regulate transcriptional rewiring to promote DNA replication stress resistance. Nat Commun 2017; 8: 558.
[PubMed]
35.
Jang C, Lahens NF, Hogenesch JB, Sehgal A: Ribosome profiling reveals an important role for translational control in circadian gene expression. Genome Res 2015; 25: 1836–1847.
[PubMed]
36.
Shigeoka T, Jung H, Jung J, Turner-Bridger B, Ohk J, Lin JQ, Amieux PS, Holt CE: Dynamic axonal translation in developing and mature visual circuits. Cell 2016; 166: 181–192.
[PubMed]
37.
Graber TE, Freemantle E, Anadolu MN, Hebert-Seropian S, MacAdam RL, Shin U, Hoang HD, Alain T, Lacaille JC, Sossin WS: UPF1 governs synaptic plasticity through Association with a STAU2 RNA granule. J Neurosci 2017; 37: 9116–9131.
[PubMed]
38.
El Fatimy R, Davidovic L, Tremblay S, Jaglin X, Dury A, Robert C, De Koninck P, Khandjian EW: Tracking the fragile X mental retardation protein in a highly ordered neuronal ribonucleoparticles population: a link between stalled polyribosomes and RNA granules. PLoS Genet 2016; 12:e1006192.
[PubMed]
39.
Ouwenga R, Lake AM, O’Brien D, Mogha A, Dani A, Dougherty JD: Transcriptomic analysis of ribosome-bound mRNA in cortical neurites in vivo. J Neurosci 2017; 37: 8688–8705.
[PubMed]
40.
Parchure A, Munson M, Budnik V: Getting mRNA-Containing ribonucleoprotein granules out of a nuclear back door. Neuron 2017; 96: 604–615.
[PubMed]
41.
Maziuk B, Ballance HI, Wolozin B: Dysregulation of RNA binding protein aggregation in neurodegenerative disorders. Front Mol Neurosci 2017; 10: 89.
[PubMed]
42.
Jonson L, Vikesaa J, Krogh A, Nielsen LK, Hansen T, Borup R, Johnsen AH, Christiansen J, Nielsen FC: Molecular composition of IMP1 ribonucleoprotein granules. Mol Cell Proteomics 2007; 6: 798–811.
[PubMed]
43.
Moschner K, Sundermann F, Meyer H, da Graca AP, Appel N, Paululat A, Bakota L, Brandt R: RNA protein granules modulate tau isoform expression and induce neuronal sprouting. J Biol Chem 2014; 289: 16814–16825.
[PubMed]
44.
Buckingham M, Liu JL: U bodies respond to nutrient stress in Drosophila. Exp Cell Res 2011; 317: 2835–2844.
[PubMed]
45.
Lui J, Castelli LM, Pizzinga M, Simpson CE, Hoyle NP, Bailey KL, Campbell SG, Ashe MP: Granules harboring translationally active mRNAs provide a platform for P-body formation following stress. Cell Rep 2014; 9: 944–954.
[PubMed]
46.
Kourtidis A, Necela B, Lin WH, Lu R, Feathers RW, Asmann YW, Thompson EA, Anastasiadis PZ: Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling. J Cell Biol 2017; 216: 3073–3085.
[PubMed]
47.
Jourdain AA, Boehm E, Maundrell K, Martinou JC: Mitochondrial RNA granules: compartmentalizing mitochondrial gene expression. J Cell Biol 2016; 212: 611–614.
[PubMed]
48.
Zaganelli S, Rebelo-Guiomar P, Maundrell K, Rozanska A, Pierredon S, Powell CA, Jourdain AA, Hulo N, Lightowlers RN, Chrzanowska-Lightowlers ZM, Minczuk M, Martinou JC: The pseudouridine synthase RPUSD4 is an essential component of mitochondrial RNA granules. J Biol Chem 2017; 292: 4519–4532.
[PubMed]
49.
Wheeler JR, Matheny T, Jain S, Abrisch R, Parker R: Distinct stages in stress granule assembly and disassembly. Elife 2016; 5:e18413.
[PubMed]
50.
Kedersha N, Ivanov P, Anderson P: Stress granules and cell signaling: more than just a passing phase? Trends Biochem Sci 2013; 38: 494–506.
[PubMed]
51.
Tourriere H, Chebli K, Zekri L, Courselaud B, Blanchard JM, Bertrand E, Tazi J: The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol 2003; 160: 823–831.
[PubMed]
52.
Ganassi M, Mateju D, Bigi I, Mediani L, Poser I, Lee HO, Seguin SJ, Morelli FF, Vinet J, Leo G, Pansarasa O, Cereda C, Poletti A, Alberti S, Carra S: A surveillance function of the HSPB8-BAG3-HSP70 Chaperone complex ensures stress granule integrity and dynamism. Mol Cell 2016; 63: 796–810.
[PubMed]
53.
Bley N, Lederer M, Pfalz B, Reinke C, Fuchs T, Glass M, Moller B, Huttelmaier S: Stress granules are dispensable for mRNA stabilization during cellular stress. Nucleic Acids Res 2015; 43:e26.
[PubMed]
54.
Lian XJ, Gallouzi IE: Oxidative stress increases the number of stress granules in senescent cells and triggers a rapid decrease in p21waf1/cip1 translation. J Biol Chem 2009; 284: 8877–8887.
[PubMed]
55.
Zhan Y, Dhaliwal JS, Adjibade P, Uniacke J, Mazroui R, Zerges W: Localized control of oxidized RNA. J Cell Sci 2015; 128: 4210–4219.
[PubMed]
56.
Aragon T, van Anken E, Pincus D, Serafimova IM, Korennykh AV, Rubio CA, Walter P: Messenger RNA targeting to endoplasmic reticulum stress signalling sites. Nature 2009; 457: 736–740.
[PubMed]
57.
Lechler MC, Crawford ED, Groh N, Widmaier K, Jung R, Kirstein J, Trinidad JC, Burlingame AL, David DC: Reduced insulin/IGF-1 signaling restores the dynamic properties of key stress granule proteins during aging. Cell Reports 2018; 18: 454–467.
[PubMed]
58.
Kramer S: RNA in development: how ribonucleoprotein granules regulate the life cycles of pathogenic protozoa. Wiley Interdiscip Rev RNA 2014; 5: 263–284.
[PubMed]
59.
Anderson P, Kedersha N, Ivanov P: Stress granules, P-bodies and cancer. Biochim Biophys Acta 2015; 1859: 861–870.
[PubMed]
60.
Bergalet J, Fawal M, Morello D, Espinos E: ALK-mediated post-transcriptional regulation: focus on RNA-binding proteins. Front Biosci (Landmark Ed) 2015; 20: 1250–1258.
[PubMed]
61.
Imig J, Kanitz A, Gerber AP: RNA regulons and the RNA-protein interaction network. Biomol Concepts 2012; 3: 403–414.
[PubMed]
62.
Ariumi Y, Kuroki M, Kushima Y, Osugi K, Hijikata M, Maki M, Ikeda M, Kato N: Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J Virol 2011; 85: 6882–6892.
[PubMed]
63.
Pager CT, Schutz S, Abraham TM, Luo G, Sarnow P: Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules. Virology 2013; 435: 472–484.
[PubMed]
64.
Martínez JP, Pérez-Vilaró G, Muthukumar Y, Scheller N, Hirsch T, Diestel R, Steinmetz H, Jansen R, Frank R, Sasse F, Meyerhans A, Díez J: Screening of small molecules affecting mammalian P-body assembly uncovers links with diverse intracellular processes and organelle physiology. RNA Biol 2013; 10: 1661–1669.
[PubMed]
© 2018 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2018
You do not currently have access to this content.
